Moderna Net Common Equity Issued/Repurchased 2017-2025 | MRNA
Moderna net common equity issued/repurchased for the twelve months ending March 31, 2025 was $171M, a 105.12% decline year-over-year.
- Moderna annual net common equity issued/repurchased for 2024 was $0.066B, a 105.96% decline from 2023.
- Moderna annual net common equity issued/repurchased for 2023 was $-1.107B, a 66.08% decline from 2022.
- Moderna annual net common equity issued/repurchased for 2022 was $-3.264B, a 345.29% increase from 2021.